GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (STU:TA50) » Definitions » Policyholder Funds

Circio Holding ASA (STU:TA50) Policyholder Funds


View and export this data going back to 2019. Start your Free Trial

What is Circio Holding ASA Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Circio Holding ASA Business Description

Traded in Other Exchanges
Address
Saint Olavs plass, Pb. 6887, Oslo, NOR, 0130
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.